Stephen Aselage
Overview
Stephen Aselage received an average of $4M in total compensation, including $402K in salary, at Retrophin from 2014 to 2019. Stephen Aselage also received $662K at BioMarin Pharmaceutical in 2006.
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2006
RetrophinDirector and Former President and Chief Executive Officer
RetrophinPresident and Chief Executive Officer
RetrophinPresident and Chief Executive Officer
RetrophinPresident, Chief Executive Officer and Director
RetrophinPresident, Chief Executive Officer and Director
RetrophinPresident, Chief Executive Officer and Director
BioMarin PharmaceuticalSVP, Global Commercial Development
Source: SEC filings on April 14, 2020, April 4, 2019, April 13, 2017, and April 30, 2007.
Related executives
We found 22 more executives who work or worked at Retrophin and BioMarin Pharmaceutical.
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
Eric Dube
Retrophin
Chief Executive Officer
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
Noah Rosenberg
Retrophin
Chief Medical Officer
William Rote
Retrophin